Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis

Digestive Diseases and Sciences

Volumn 41, Issue 3, 1996, Pages 614-620

  Mantyh, Christopher R ^a   Maggio, John E ^b   Mantyh, Patrick W ^b   Vigna, Steven R ^b   Pappas, Theodore N ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Inflammation; Inflammatory bowel disease; Pseudomembranous colitis; Receptors; Substance P; Toxin A

Indexed keywords

SUBSTANCE P RECEPTOR; TOXIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE; COMPUTER ASSISTED TOMOGRAPHY; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS;

ADULT; BLOOD VESSELS; COLON; COMBINED MODALITY THERAPY; EMERGENCIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LYMPHOID TISSUE; RECEPTORS, NEUROKININ-1;

EID: 0029871467     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02282350     Document Type: Article

References (22)

1. Bartlett JG, Chang TW, Gurwith M, Garbach SL, Onderdonk AB: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298:531-534, 1978
2. Price AB, Davies DR: Pseudomembranous colitis. J Clin Pathol 30:1-12, 1977
3. Bartlett JG: Antibiotic-associated colitis. Dis Month 30:1-54, 1984
4. Lyerly DM, Krivan HC, Wilkins TD: Clostridium difficile: Its disease and toxins. Clin Microbiol Rev 1:1-18, 1988
5. Kelly CP, Pothoulakis C, LaMont JT: Clostridium difficile colitis. N Engl J Med 330:257-262, 1994
6. Pothoulakis C, LaMont JT, Eglow R, Ciao N, Rubins JB, Theoharides TC, Dickey BF: Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest 88:119-125, 1991
7. Kelly CP, Becker S, Linevsky JK, Joshi MA, O'Keane JC, Dickey BF, LuMont JT, Pothoulakis C: Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 93:1257-1265, 1994
8. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SF: CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci USA 91:947-951, 1994
9. Barnes PJ: Sensory nerves, neuropeptides, and asthma. Ann NY Acad Sci 629:359-370, 1991
10. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI: Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547-549, 1984
11. Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP Jr, Vigna SR, Maggio JE, Kruger L, Mantyh PW: Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venulles, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85:3235-3239, 1988
12. Mantyh PW, Catton MD, Boehmer CG, Welton ML, Passaro EP Jr, Maggio JE, Vigna SR: Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons. Peptides 10:627-645, 1989
13. Mantyh CR, Vigna SR, Bollinger RR, Mantyh PW, Maggio JE, Pappas TN: Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 109:850-860, 1995
14. Triadafilopoulos G, Pothoulakis C, O'Brien MJ, LaMont JT: Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 43:273-279, 1987
15. Mitchell TJ, Ketley JM, Haslam SC, Stephen J, Burdon DW, Candy DCA, Daniel R: Effect of toxin A and B of Clostridiuin difficile on rabbit ileum and colon. Gut 27:78-85, 1986
16. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, Pothoulakis C: Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107:657-665, 1994
17. Lotz M, Vaughan JH, Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241:1218-1221, 1988
18. Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D: Mast-cell heterogeneity: Effects of neuroenteric peptides on histamine release. J Immunol 135:1331-1337, 1985
19. Wozniak A, McLennan G, Betts WH, Murphy GA, Scicchitano R: Activation of human neutrophils by substance P: Effect on FMLP-stimulated oxidative and arachidonic acid metabolism and on antibody-dependent cell-mediated cytotoxicity. Immunology 68:359-364, 1989
20. Lembeck F, Holzer P: Substance P as a neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310:175-183, 1979
21. Nakagawa N, Iwamoto I, Yoshida S: Effect of substance P on the expression of an adhesion molecule ICAM-1 in human vascular endothelial cells. Regul Pept 46:223-224, 1993
22. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF: Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 177:1269-1276, 1993